Scopus (CiteScore 2022 =3.0, Q3) , ISC
The potential of 12 flavonoid compounds as alzheimer's inhibitors through an in silico approach
The potential of 12 flavonoid compounds as alzheimer's inhibitors through an in silico approach

Marisca Evalina Gondokesumo; Faisal Akhmal Muslikh; Rizki Rahmadi Pratama; Burhan Ma’arif; Dyah Aryantini; Reza Alrayan; Dewi Luthfiana

Articles in Press, Accepted Manuscript, Available Online from 10 November 2023

https://doi.org/10.48309/ecc.2023.419701.1702

Abstract
  Neurodegenerative disorders (NDD) are age-related condition characterized by a progressive decline in brain functions. This condition has influenced more than 8% of the adult population ...  Read More
Natural products for attenuating Alzheimer's disease: A narrative review
Natural products for attenuating Alzheimer's disease: A narrative review

Noora Thamer Abdulaziz; Fadia Yassir Al-bazzaz; Yasser Fakri Mustafa

Volume 5, Issue 4 , April 2023, , Pages 358-370

https://doi.org/10.22034/ecc.2023.377844.1579

Abstract
  Alzheimer's disease (AD) is one of the most common neurodegenerative conditions and a major contributor to dementia in the elderly and its prevalence is rising quickly. There are currently ...  Read More
Role of pyridazine analogs as acetylcholinesterase inhibitor: An approach for management of alzheimer’s disease
Role of pyridazine analogs as acetylcholinesterase inhibitor: An approach for management of alzheimer’s disease

Saad Alghamdi; Mohammad Asif

Volume 3, Issue 7 , July 2021, , Pages 435-442

https://doi.org/10.22034/ecc.2021.229705.1168

Abstract
  Alzheimer's disease (AD) is a neurodegenerative disorder causing failure of cognitive aptitude and performance irregularities, resulting in degradation of cerebral and psychological ...  Read More